Home FEATURED NEWS KKR Said to Mull Stake Sale in India’s $3 Billion JB Pharma

KKR Said to Mull Stake Sale in India’s $3 Billion JB Pharma

0

[ad_1]

Follow Bloomberg India on WhatsApp for unique content material and evaluation on what billionaires, companies and markets are doing. Sign up here.

KKR & Co. is exploring choices together with promoting its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid curiosity from potential consumers, based on folks conversant in the matter.

[adinserter block=”4″]

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here